Nordson Corporation
233.18-2.14 (-0.91%)
Oct 29, 4:00:00 PM EDT · NasdaqGS · NDSN · USD
Key Stats
Market Cap
13.10BP/E (TTM)
29.33Basic EPS (TTM)
7.95Dividend Yield
0.01%Recent Filings
8-K
10-Q
Q3 FY2025 results
Nordson Corporation posted solid Q3 FY2025 results, with sales climbing 12.1% year-over-year to $741.5M, fueled by the Atrion acquisition and robust growth in Advanced Technology Solutions, though Industrial Precision Solutions held steady. Operating profit rose 12.4% to $187.8M, holding a steady 25.3% margin despite divestiture charges of $12.2M tied to exiting medical contract manufacturing; gross margin dipped 1.0 point to 54.8% on mix shifts. Diluted EPS edged up 8.8% to $2.22, aligning with 56.7M shares, while YTD sales grew 4.9% to $2.0B but net income fell 3.6% to $332.8M amid higher interest from acquisition debt. Cash swelled to $147.8M, with operating cash flow surging 12.3% to $516.3M and free cash flow at $467.3M after $49.0M capex; total debt stood at $2.1B including a $243.0M revolver draw, with $824.1M availability. The August 2024 Atrion buyout closed for $790.0M cash, adding $494.3M goodwill and $129.6M intangibles amortized over 15-19 years in Medical and Fluid Solutions. Yet tariff hikes could squeeze margins further.
8-K
Nordson Q3 sales up 12%
Nordson Corporation reported third-quarter fiscal 2025 sales of $742 million, up 12% year-over-year, driven by 8% from acquisitions and 2% organic growth, while adjusted EPS rose 13% to $2.73 amid strong EBITDA margins. The board authorized an additional $500 million share repurchase, boosting total capacity to $793 million, signaling confidence in capital allocation. Backlog dipped 5% sequentially. Yet, full-year guidance holds firm.
8-K
Nordson appoints new CAO
Nordson Corporation appointed Joseph M. Rutledge as Vice President and Chief Accounting Officer on July 14, 2025, replacing Stephen Shamrock who separated from the role on July 10. Rutledge, 46, brings 15 years from Eaton, including oversight of global financial statements and acquisition due diligence. This leadership shift bolsters Nordson's accounting and reporting expertise amid ongoing operations. No related transactions disclosed.
10-Q
Q2 FY2025 results
Nordson Corporation posted Q2 FY2025 sales of $682.9M, up 5.0% y/y but flat q/q (derived), fueled by 20% y/y growth in Medical and Fluid Solutions from the Atrion acquisition while Industrial Precision Solutions dipped 7.6% y/y on softer systems demand. Gross margin held at 54.7%, down 1.5% y/y, as operating profit edged up 0.1% y/y to $168.8M despite higher costs; diluted EPS fell 3.9% y/y to $1.97, reconciling to 57,038 diluted shares with no anti-dilution flagged. YTD sales rose 1.1% y/y to $1.3B, but operating profit dropped 5.6% y/y to $309.7M and EPS slid 8.4% y/y to $3.62, pressured by acquisitions and foreign currency losses. Cash climbed to $130.2M with $278.3M operating cash flow, yielding $240.9M free cash flow (derived); total debt stood at $2.2B including $243M revolver draw, with $806.5M availability and covenant compliance. Closed Atrion in August 2024 for $790M all-cash, recognizing $494.3M goodwill and $129.6M intangibles amortized over 15-19 years. Acquisitions drive momentum, yet tariff shifts pose trade risks.
IPO
Website
Employees
Sector
Industry
ATS
ATS Corporation
27.32+0.15
DCI
Donaldson Company, Inc.
83.58+0.80
EMR
Emerson Electric Company
136.43+1.91
FANUF
Fanuc Corporation
32.42+0.42
IEX
IDEX Corporation
173.40+6.45
IR
Ingersoll Rand Inc.
79.70+0.85
ITW
Illinois Tool Works Inc.
242.03-3.84
NTIC
Northern Technologies Internati
7.66+0.00
PH
Parker-Hannifin Corporation
775.03+8.02
RRX
Regal Rexnord Corporation
150.63+5.92